{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-25-008732","form_type":"8-K","ticker":"ACTU","cik":"0001652935","company_name":"ACTUATE THERAPEUTICS, INC.","filed_at":"2025-11-28T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.051055+00:00","generated_at":"2026-05-16T16:09:53.997352+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Actuate Therapeutics enters $100M ATM equity offering agreement with B. Riley and Craig-Hallum","bullets":["Agreement allows sale of up to $100M of common stock through agents B. Riley Securities and Craig-Hallum Capital Group.","Sales will be made under existing S-3 shelf registration; agents receive 3.0% commission on gross proceeds.","Offers may be executed as at-the-market, privately negotiated, or block transactions at company's discretion.","Company provides customary indemnification to the sales agents."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-25-008732","json":"https://secwatch.observer/filing/0001683168-25-008732.json","markdown":"https://secwatch.observer/filing/0001683168-25-008732.md","text":"https://secwatch.observer/filing/0001683168-25-008732.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1652935/000168316825008732/0001683168-25-008732-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1652935/000168316825008732/actuate_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T16:09:53.997352+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a26286b4f7979023ab024e3e407ef9542d57ba35","claim":"ACTUATE THERAPEUTICS, INC. entered into At the Market Issuance Sales Agreement with B. Riley Securities, Inc. and Craig-Hallum Capital Group LLC valued at aggregate offering price of up to $100,000,000 (effective 2025-11-28).","evidence_excerpt":"On November 28, 2025, Actuate Therapeutics, Inc. (the “Company”) entered into an At the Market Issuance Sales Agreement (the “Agreement”) with B. Riley Securities, Inc. and Craig-Hallum Capital Group LLC (each a “Sales Agent” and collectively the “Sales Agents”) under which the Company may offer and sell, from time to time at its sole discretion, shares of its common stock, $0.000001 par value per share (“Common Stock”), to or through the Sales Agents, as its agents, having an aggregate offering price of up to $100,000,000.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1652935/000168316825008732/0001683168-25-008732-index.htm","confidence":0.99,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"atm program"},{"label":"Counterparty","value":"B. Riley Securities, Inc. and Craig-Hallum Capital Group LLC"},{"label":"Value","value":"aggregate offering price of up to $100,000,000"},{"label":"Effective","value":"2025-11-28"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}